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NeuraminidaseBovine adenovirus serotype 3 (BAd3) and porcine adenovirus serotype 3 (PAd3) entry into the host cells is
independent of Coxsackievirus adenovirus receptor and integrins. The role of sialic acid in BAd3 and PAd3
entry was investigated. Removal of sialic acid by neuraminidase, or blocking sialic acid by wheat germ
agglutinin lectin signiﬁcantly inhibited BAd3, but not PAd3, transduction of Madin–Darby bovine kidney cells.
Maackia amurensis agglutinin or Sambucus nigra (elder) agglutinin treatment efﬁciently blocked BAd3
transduction suggesting that BAd3 utilized α(2,3)-linked and α(2,6)-linked sialic acid as a cell receptor. BAd3
transduction of MDBK cells was sensitive to sodium periodate, bromelain, or trypsin treatment indicating
that the receptor sialoconjugate was a glycoprotein rather than a ganglioside. To determine sialic acid-
containing cell membrane proteins that bind to BAd3, virus overlay protein binding assay (VOPBA) was
performed and showed that sialylated cell membrane proteins in size of approximately 97 and 34 kDa bind to
BAd3. The results suggest that sialic acid serves as a primary receptor for BAd3.
© 2009 Elsevier Inc. All rights reserved.IntroductionAdenovirus (Ad) entry into the host cells is initiated by attachment
of the viral particle with a primary receptor on the cell surface
followed by interactions with a secondary receptor leading to virus
endocytosis into a clathrin-coated vesicle and subsequent transporta-
tion to the endosome (Berk, 2007). Acidiﬁcation of the endosome
leads to partial disassembly of the capsid followed by transport of the
viral genome into the host cell nucleus. For subgroup C human Ad
(HAd) such as HAd serotype 5 (HAd5), the primary cell receptor is
Coxsackievirus adenovirus receptor (CAR), an immunoglobulin super-
family molecule shared as a receptor by Coxsackieviruses and Ads
(Bergelson et al., 1997). The interaction between the viral penton base
and the secondary receptor αv integrins is essential for HAd5
internalization into the host cells. In addition to CAR, several other
cell surface molecules have been identiﬁed as primary or secondary
receptors involved in attachment or internalization of many other Ads
(Sharma et al., 2009; Zhang and Bergelson, 2005). These receptor
molecules include CD46 (Gaggar et al., 2003; Segerman et al., 2003),
CD80 (B7-1)/CD86 (B7-2) (Short et al., 2004), major histocompat-
ibility complex class I (MHC I) (Hong et al., 1997), vascular cell
adhesion molecule-1 (VCAM-1) (Chu et al., 2001), heparan sulfate
proteoglycans (HSPGs) (Dechecchi et al., 2000) and sialic acid
(Arnberg et al., 2000a).me Corporation, 5 Mountain
l rights reserved.A variety of nonhuman Ads have been proposed as promising gene
delivery vectors (Bangari and Mittal, 2006). Bovine adenovirus
serotype 3 (BAd3) and porcine adenovirus serotype 3 (PAd3) belong
to the genus Mastadenovirus of family Adenoviridae and are isolated
from a normal calf or pig, respectively. The transcriptional map of
BAd3 or PAd3 is similar to that of HAd5 (Reddy et al., 1998a, 1998b).
We have previously demonstrated that BAd3 or PAd3 entry is
independent of CAR and integrins, and that BAd3, PAd3 and HAd5
cellular receptors are distinct (Bangari et al., 2005a; Bangari and
Mittal, 2005).
A number of viruses including some serotypes of HAds have been
shown to utilize sialic acid molecules as a cellular receptor (Lehmann
et al., 2006). Subgroup D Ads, HAd8, HAd19a and HAd37, which are
frequently associated with epidemic keratoconjunctivitis (Gordon et
al., 1996; Kemp et al., 1983), utilize sialic acid as a cell receptor
(Arnberg et al., 1997; Arnberg et al., 2000a; Lehmann et al., 2006). In
this manuscript, we endeavor to determine whether sialic acid plays a
role in BAd3 or PAd3 entry. Our experiments involve the evaluation of
BAd3 or PAd3 vector [expressing the green ﬂuorescent protein (GFP)
gene] transduction of Madin–Darby bovine kidney (MDBK) cells
pretreated with 1) neuraminidase to remove cell surface sialic acid
molecules, 2) wheat germ agglutinin lectin (WGA) to block avail-
ability of sialic acid molecules, 3) sialic acid linkage-speciﬁc lectins for
competitive inhibition of Ad transduction, and 4) with either sodium
periodate to remove sialic acid-conjugated carbohydrates or proteases
to remove sialic acid-conjugated proteins. Our results provide strong
evidence for sialic acid as a component of BAd3 receptor, whereas
PAd3 entry was independent of sialic acid. Furthermore, to ﬁnd out
sialic acid-containing cell membrane proteins that attach to BAd3,
virus overlay protein binding assay (VOPBA) was conducted. Sialic
Fig. 1. Sialic acid on MDBK cell surface is sensitive to neuraminidase treatment. MDBK
cells in monolayer cultures were treated with 1 mU/ml of Vibrio cholerae neuraminidase
or PBS at 37 °C for 2 h followed by staining with TRITC-conjugated WGA lectin at room
temperature for 15 min. The cells were washed with PBS and then examined under a
ﬂuorescence microscope. (A) In PBS-treated cells, intense orange-red labeling with
TRITC-conjugated WGA at the periphery of MDBK cells was observed indicating the
presence of cell surface sialic acid molecules. (B) Pretreatment of cells with
neuraminidase abolished surface staining with TRITC-conjugated WGA.
Fig. 2. Neuraminidase treatment of MDBK cells inhibits transduction by BAd3 vector.
MDBK cells treated with neuraminidase (0, 0.01, 0.1, 1, or 10 mU/ml) were incubated
with BAd-GFP, EGFPNAd5F37, HAd-GFP, or PAd-GFP and at 48 h post-transduction,
transduced cells were analyzed by ﬂow cytometry. Percent relative transduction of
different groups is shown in relation to transduction of untreated cells that was
normalized to 100%. For each group, the mean value from triplicate samples±standard
deviation is shown.
163X. Li et al. / Virology 392 (2009) 162–168acid-containing cell membrane proteins of approximately 97 and
34 kDa demonstrated association to BAd3.
Results
Enzymatic removal of cell surface sialic acid inhibits BAd3 transduction
To investigate the role of sialic acid in BAd3 or PAd3 entry, we used
MDBK cells for transduction assays. The presence of sialic acid on the
MDBK cell surface was conﬁrmed by labeling the cells with a
ﬂuorescent dye, tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated wheat germ agglutinin (WGA) from Triticum vulgaris
that binds to sialic acid. To examine the effect of neuraminidase
treatment on the surface sialic acid molecules, untreated and
neuraminidase-treated MDBK cells were examined by staining withTRITC-conjugated WGA. As shown in Fig. 1A, the speciﬁc cell
membrane staining was observed in untreated cells. In neuramini-
dase-treated cells, the circular membrane staining was diminished
compared to the untreated cells indicating that MDBK cells have sialic
acid molecules on the surface and neuraminidase treatment was
effective in the removal of these molecules (Fig. 1B).
In order to examine if BAd3 or PAd3 utilizes sialic acid as a cell
receptor, MDBK cells were treated with neuraminidase. For viral
transduction experiments, BAd-GFP, a replication-defective BAd3
vector expressing the GFP reporter gene (Bangari et al., 2005b) and
PAd-GFP, a replication-defective PAd3 vector expressing GFP (Bangari
and Mittal, 2004) were used in these experiments. As a control,
EGFPNAd5F37, a HAd5 vector with a hybrid ﬁber knob from HAd37
and the enhanced green ﬂuorescent gene (EGFP) expression cassette
(Arnberg et al., 2000a; Cashman et al., 2004), was included in our
experiments. EGFPNAd5F37 has been shown to bind to the sialic acid
receptor (Cashman et al., 2004). HAd-GFP, a HAd5 vector expressing
GFP was used as a negative control. As expected, treatment of MDBK
cells with neuraminidase inhibited transduction of EGFPNAd5F37 by
43% compared to the untreated group (Fig. 2). Interestingly, pretreat-
ment of MDBK cells with neuraminidase at concentrations of 0.1, 1, or
10 mU/ml reduced BAd-GFP transduction by 87%, 93% and 88%,
respectively. No inhibition in transduction by HAd-GFP or PAd-GFP
was observed indicating that the cell surface sialic acid was not
involved in PAd3 or HAd5 entry.
Pretreatment with sialic acid-binding lectin WGA blocks BAd3
transduction
To further conﬁrm the role of sialic acid in BAd3 entry, a sialic acid-
binding molecule, WGA lectin, was used to treat MDBK cells prior to
virus transduction. Preincubation of MDBK cells with WGA demon-
strated a dose-dependent inhibition in BAd-GFP transduction. BAd-
GFP transduction was reduced approximately 97% when the cells
were preincubated with 0.05 mg/ml or higher concentrations of WGA
(Fig. 3). There was no strong inhibition in the transduction efﬁciency
of EGFPNAd5F37 in cells treatedwithWGA (Fig. 3). This may be due to
the utilization of other potential receptor/s by this chimeric vector.
WGA preincubation did not block the attachment of HAd-GFP and
PAd-GFP to MDBK cells (Fig. 3). These results further highlighted the
importance of cell surface sialic acid in BAd3 entry.
Fig. 3. Pretreatment of MDBK cells with WGA lectin inhibits BAd3 transduction vector.
MDBK cells preincubated with Triticum vulgaris WGA lectin (0, 0.01, 0.05, 0.1, or
0.5 mg/ml) were incubated with BAd-GFP, EGFPNAd5F37, HAd-GFP, or PAd-GFP and
at 48 h post-transduction, transduced cells were analyzed by ﬂow cytometry. Percent
relative transduction of different groups is shown in relation to transduction of
untreated cells that was normalized to 100%. For each group, the mean value from
triplicate samples±standard deviation is shown.
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WGA lectin clearly showed that PAd3 entry into the host cells was
independent of sialic acid molecules on the cell surface. Therefore,
additional experiments were directed to further explore the nature of
sialic acid molecules that are involved in BAd3 entry.
Both α(2,3)-linked and α(2,6)-linked sialylated glycoconjugates are
involved in BAd3 binding
Tissue tropism of some of the Ads is closely related with
interaction between viral ﬁber knob domain and linkage-speciﬁc
sialic acid receptors. HAd37 has been shown to predominantly bind to
α(2,3)-linked sialic acid rather thanα(2,6)-linked sialic acid (Arnberg
et al., 2000a). Identiﬁcation of α(2,3)-linked or α(2,6)-linked sialic
acid molecules on the cell surface in the lower or upper respiratory
tract, respectively in humans (van Riel et al., 2007) certainly holds
considerable importance for Ad vectors and their tropism for gene
delivery.
To further analyze the nature of the sialic acid receptor involved in
BAd3 entry, linkage-speciﬁc lectins were utilized to block the cell
surface sialic acid molecules prior to transduction with EGFPNAd5F37Fig. 4. BAd3 utilizes both α(2,3)-linked and α(2,6)-linked sialic acid as a cellular receptor
agglutinin (SNA) (0, 0.01, 0.1, 1, or 10 mg/ml) were incubated with BAd-GFP or EGFPNAd5
Percent relative transduction of different groups is shown in relation to transduction of untr
samples±standard deviation is shown.or BAd-GFP. It is known that Maackia amurensis agglutinin (MAA)
attaches to α(2,3)-linked sialic acid; while Sambucus nigra agglutinin
(SNA) binds to α(2, 6)-linked sialic acid (Varki and Schauer, 1999). In
the present study, MDBK cells were treated with either MAA or SNA
prior to transductionwith EGFPNAd5F37 or BAd-GFP and at 48 h post-
transduction, cells were harvested and analyzed by ﬂow cytometry.
There was a dose-dependent inhibition in transduction with EGFP-
NAd5F37 when cells were pretreated with MAA or SNA (Fig. 4);
however, the reduction in transduction was more pronounced with
the MAA treatment group. In the case of BAd-GFP, there was
signiﬁcant decline in transduction of cells pretreated with either
MAA or SNA (Fig. 4). Pretreatment of MDBK cells with 0.5 mg/ml of
MAA or SNA resulted in a drop in BAd-GFP transduction by 90% or 59%,
respectively. It appears that BAd3 utilizesα(2,3)-linked sialic acid and
α(2,6)-linked sialic acid as a receptor for virus attachment with a
preference for α(2,3)-linked sialic acid.
Sialylated carbohydrate is involved in BAd3 binding
It has been shown that sodium periodate (NaIO4) can destroy
carbohydrate moieties by oxidation of vicinal hydroxyl groups on
sugars to dialdehydes at acidic pH without altering protein or lipid
structures (Stevenson et al., 2004). To further examine the role of cell
surface carbohydrate in BAd3 binding, MDBK cells were pretreated
with NaIO4 followed by transduction with either EGFPNAd5F37 or
BAd-GFP. Pretreatment of MDBK cells with NaIO4 at a concentration of
1 mM reduced BAd-GFP transduction by 70% compared to the
untreated group (Fig. 5) suggesting that sialic acid-containing
carbohydrate is a component of the BAd3 receptor. As a control, a
62% reduction in EGFPNAd5F37 transduction was observed in the
group treated with NaIO4 at a concentration of 1 mM compared to the
untreated group (Fig. 5).
Sialic acid molecules recognized by BAd3 are localized on glycoproteins
rather than gangliosides
It is known that sialic acid saccharides are expressed on both
glycoproteins and glycolipids (gangliosides). To examine if BAd3 virus
binding to cells is sensitive to protease treatment, MDBK cells were
treated with trypsin or bromelain prior to transduction with
EGFPNAd5F37 or BAd-GFP. As shown in Fig. 6, trypsin treatment of. MDBK cells pretreated with Maackia amurensis agglutinin (MAA) or Sambucus nigra
F37 and at 48 h post-transduction, transduced cells were analyzed by ﬂow cytometry.
eated cells that was normalized to 100%. For each group, the mean value from triplicate
Fig. 5. BAd3-interacting sialic acid-containing cell surface molecule contains carbohy-
drate moieties. MDBK cells treated with sodium periodate (0, 0.1 and 1 mM) were
incubated with BAd-GFP or EGFPNAd5F37 and at 48 h post-transduction, transduced
cells were analyzed by ﬂow cytometry. Percent relative transduction of different groups
is shown in relation to transduction of untreated cells that was normalized to 100%. For
each group, the mean value from triplicate samples±standard deviation is shown.
Fig. 7. BAd3 receptor is associated with approximately 97 and/or 34 kDa neuramini-
dase-sensitive proteins. Cell membrane preparations from neuraminidase-treated or
untreated MDBK cells were analyzed by virus overlay protein binding assay (VOPBA) as
described in materials and methods. Approximately 97 kDa (upper arrow) and 34 kDa
(lower arrow) proteins in the untreated cell membrane preparation were detected
using BAd3 overlay (lane 2). The binding of BAd3 to these cell membrane proteins was
sensitive to neuraminidase (lane 1). Lanes 1 and 3 represent cell membrane
preparations from neuraminidase-treated MDBK cells, whereas lanes 2 and 4 represent
cell membrane preparations from untreated cells. Lanes 1 and 2 were overlaid with
BAd3, whereas lanes 3 and 4 were similarly treated but without the virus.
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treatment reduced BAd-GFP binding by 30% compared to the
untreated group suggesting that the sialic acid-containing BAd3
receptor has a protein component. As expected, approximately a 63%
or 78% reduction in EGFPNAd5F37 transduction was observed in
trypsin- or bromelain-treated groups, respectively, compared to the
untreated groups (Fig. 6).
Neuraminidase treatment blocks BAd3 binding to MDBK cellular
membrane protein
VOPBA is a standard technique to identify cell molecules involved
in virus binding. We observed that neuraminidase treatment of MDBK
cells resulted in reduced transduction of BAd-GFP. To examine
whether neuraminidase treatment of MDBK cells affects BAd3 binding
to membrane proteins, we performed a VOPBA assay using cell
membrane fractions from neuraminidase-treated or untreated MDBK
cells. As shown in Fig. 7, a prominent band of approximately 97 kDa
and a faint band of approximately 34 kDa (lane 2) were observed in
the untreated MDBK cell membrane protein sample, which were
absent in the membrane sample obtained from neuraminidase-
treated cells (lane 1) or the untreated cell membrane protein samples
without the virus overlay (lanes 3 and 4). It appears that the removal
of sialic acid molecules from 97 kDa and 34 kDa proteins resulted inFig. 6. Sialic acid-containing receptor for BAd3 is sensitive to protease treatment. MDBK cell
incubatedwith BAd-GFP or EGFPNAd5F37 and at 48 h post-transduction, transduced cells we
in relation to transduction of untreated cells that was normalized to 100%. For each group,the loss of BAd3 binding. Either or both of these two proteins
represent sialic acid-containing potential receptor candidates for
BAd3. Further characterization of these two proteins will be carried
out in future studies.s treated with trypsin (0, 50, or 500 μg/ml) or bromelain (0, 200, or 2000 mU/ml) were
re analyzed by ﬂowcytometry. Percent relative transduction of different groups is shown
the mean value from triplicate samples±standard deviation is shown.
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A variety of Ad vectors derived from human or nonhuman species
have shown distinct advantages as gene delivery vehicles for
therapeutic and prophylactic applications. Ad entry into host cells
involves speciﬁc interactions between cell surface receptors and viral
proteins. Receptor usage by viruses is a major determinant of their
tissue tropism, an important consideration for the design of safe and
effective gene transfer vectors. The primary attachment is followed by
interactions between the virus and a secondary receptor which trigger
virus entry (Lehmann et al., 2006).
Cell entry by BAd3 and PAd3 has been reported to be independent
of the HAd receptors, CAR and integrins, and BAd3 and PAd3 receptors
are distinct from the HAd5 receptor (Bangari et al., 2005a; Bangari and
Mittal, 2004, 2005). In this study, we have presented a number of lines
of evidence indicating that sialic acid serves as a primary cellular
receptor for BAd3 entry. Sialic acid molecules were removed from
MDBK cell surfaces with neuraminidase treatment, which led to a
dose-dependent reduction in BAd3 transduction. Since virus and cell
receptor interaction experiments were performed on ice, it was
expected that cell surface sialic acid moieties were involved in the
initial stage (attachment) of BAd3 entry. Competitive inhibition assay
with a sialic acid-binding lectin, WGA, further conﬁrmed that sialic
acid molecules were utilized as a cell receptor for BAd3.
Use of neuraminidase treatment demonstrated the utilization of
sialic acid as a receptor for HAd37 (Arnberg et al., 2000a). Sialic acid
serves as a cellular receptor for some of the subgroup D HAds (HAd8,
HAd19a and HAd37) (Arnberg et al., 2000a, 2000b; Arnberg et al.,
2002). Neuraminidase or WGA treatment of cells prior to vector
transduction clearly demonstrated that sialic acid did not serve as a
receptor for PAd3. More work is needed to identify the primary
receptor for PAd3 entry into susceptible cells.
The discrepancy in transduction levels of EGFPNAd5F37 in cells
treated with neuraminidase or WGA may be partly due to the
involvement of other potential receptors since it is a HAd5-based
chimeric vector carrying a HAd37 ﬁber knob. Ad attachment can occur
following direct interaction between the penton base and cell surface
integrins independent of the ﬁber knob-primary receptor interactions
(Huang et al., 1996). Fiber-deﬁcient HAd2 virions can infect CAR-
negative monocytic cells by a mechanism that involves attachment to
integrins αMβ2 and αLβ2, followed by an interaction with αv
integrins which is needed for internalization (Huang et al., 1996).
MAA and SNA lectins have the ability to speciﬁcally bind α(2,3)-
linked sialic acid orα(2,6)-linked sialic acid, respectively (Lehmann et
al., 2006). It has been shown that HAd37 can speciﬁcally bind to
α(2,3)-linked sialic acid rather thanα(2,6)-linked sialic acid (Arnberg
et al., 2000a). Moreover, it has been demonstrated that MAA rather
than SNA treatment can signiﬁcantly reduce EGFPNAd5F37 binding to
Chang C cells and human lung carcinoma (A549) cells (Cashman et al.,
2004). Our results with EGFPNAd5F37 in cells pretreated with MAA or
SNA were consistent with previous observations. However, in our
experiment, both MAA and SNA signiﬁcantly blocked BAd3 transduc-
tion of MDBK cells suggesting that BAd3 utilizes both α(2,3)-linked
sialic acid and α(2,6)-linked sialic acid as a cell receptor with a slight
preference for α(2,3)-linked sialic acid.
Sodium periodate has the ability to destroy carbohydrate moieties
without altering the protein or lipid structures (Stevenson et al.,
2004). In our study, MDBK cells pretreated with NaIO4 showed that
the sialic acid-containing BAd3 receptor has a carbohydrate compo-
nent. Additional results with trypsin or bromelain treatment demon-
strated that BAd3 receptor contains a protein component with
terminal sialic acid. Similarly, HAd37 binding to Chang C (Wu et al.,
2001) and CHO cells (Arnberg et al., 2000a) was reduced when these
cells were pretreated with general or speciﬁc proteases. This
phenomenonwas also observed for EGFPNAd5F37 binding to protease
pretreated Chang C and A549 cells (Cashman et al., 2004). VOPBAfurther demonstrated that approximately 97 and/or 34 kDa cell
membrane proteins with sialic acid molecules may serve as receptor/s
for BAd3. Further work is needed to characterize these cell membrane
proteins.
Differences in the receptor usage by diverse Ad serotypes provide
the distinctive opportunity to exploit the natural diversity of Ad
tropism in designing safe and efﬁcient vectors for various gene
therapy applications. Sialic acid-binding HAds or chimeric HAd5
vectors with ﬁber knob derived from subgroup D HAds result in
transduction of cell types, such as hematopoietic cells including
dendritic cells, which are refractory to transduction by CAR-utilizing
HAd vectors (Horvath and Weber, 1988; Rea et al., 2001). The
observation that BAd3 utilizes both α(2,3)-linked and α(2,6)-linked
sialic acid as a cell receptor will further widen the repertoire of Ad
receptors and will be of signiﬁcance in unraveling the complexity of
Ad tissue tropism.
Materials and methods
Cells and viruses
MDBK cells were grown as monolayer cultures in minimum
essential medium (MEM) with 10% FetalClone III (Hyclone of Thermo
Fisher Scientiﬁc Inc., Waltham, MA) and gentamicin (50 μg/ml). Cells
were harvested with phosphate-buffered saline (PBS)-EDTA (10 mM
sodium phosphate buffer, 150 mM NaCl, and 2 mM EDTA, pH 7.4) to
keep the cell receptors intact. Suspended cells were washed twice
with binding buffer (BB: PBS with 1% bovine serum albumin, BSA) to
remove EDTA. Treated or untreated MDBK cells were transduced with
either BAd-GFP, PAd-GFP, HAd-GFP or EGFPNAd5F37 and 2×105 cells
were seeded per well of a 24-well plate in triplicate and incubated for
48 h in a CO2 incubator in MEM containing 10% FetalClone III.
Construction and propagation of BAd-GFP, PAd-GFP, and HAd-GFP
have been described previously (Bangari et al., 2005a; Bangari and
Mittal, 2004). BAd-GFP, PAd-GFP, and HAd-GFP were grown in FBRT-
HE1 [fetal bovine retinal cells that express HAd5 E1] (van Olphen et al.,
2002), FPRT-E1-5 [fetal porcine retinal cells that express HAd5 E1]
(Bangari andMittal, 2004) and 293 cell line [human embryonic kidney
cell line that expresses HAd5 E1 proteins] (Graham et al., 1977),
respectively. The chimeric vector, EGFPNAd5F37 (Cashman et al.,
2004) that contains the HAd5 capsid with ﬁber knob domain from
HAd37 was kindly provided by Dr. R. Kumar-Singh, Department of
Ophthalmology and Visual Sciences, and Human Genetics, University
of Utah, Salt Lake City, UT) and was propagated in 293 cells. Wild type
BAd3 was propagated in MDBK cells as previously described (Bangari
et al., 2005b). Since BAd-GFP, PAd-GFP, HAd-GFP, or EGFPNAd5F37 has
variable transduction efﬁciency in MDBK cells, various dilutions of Ad
vector were used to obtain transduction efﬁcacy of approximately
25–30%. To obtain this efﬁciency for BAd-GFP, PAd-GFP, HAd-GFP, or
EGFPNAd5F37, a multiplicity of infection (m.o.i.) of 0.5, 1.0, 3.5, and
0.5 tissue culture infectious dose 50 (TCID50) per cell was used.
At 48 h post-transduction, cells were trypsinized, washed once
with PBS and ﬁxed with 2% paraformaldehyde, and the percentage of
GFP-expressing cells was determined by ﬂow cytometry (BD FACS
CantoII, BD Bioscience, San Jose, CA). All experiments were carried out
in triplicate. Negative and positive controls were kept for each
experiment to make sure the cells used in the experiments were
competent for virus uptake.
Wheat germ agglutinin (WGA) staining
MDBK cells in monolayer cultures in 8-well chamber slides (Nalge
Nunc International, Naperville, IL) were treated with neuraminidase
at a concentration of 1mU/ml at 37 °C for 2 h. Subsequently, cells were
washed with PBS twice and then stained with 150× diluted TRITC-
conjugated WGA (E. Y. Laboratories Inc., San Mateo, CA) at room
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ﬂuorescent microscope and images were captured at 40× magniﬁca-
tion using same setting for treatment and control groups. MDBK cell
monolayers without neuraminidase treatment were kept as a positive
control.
Neuraminidase treatment
A total of 2×105 MDBK cells were treated with Vibrio cholerae
neuraminidase (Sigma-Aldrich, St. Louis MO) at concentrations of 0,
0.01, 0.1, 1.0 or 10 mU/ml in BB and incubated for 2 h at 37°C.
Subsequently, cells were washed with BB and suspended in 100 μl of
BB and kept on ice for 10 min. Treated or untreated MDBK cells were
transduced either with BAd-GFP, PAd-GFP, HAd-GFP, or EGFP-
NAd5F37 on ice for 1 h. Cells washed with MEM with 10% FetalClone
III were seeded in 24-well plates and incubated in a CO2 incubator in
MEM containing 10% FetalClone III. At 48 h post-transduction, cells
were trypsinized, washed once with PBS and ﬁxed with 2%
paraformaldehyde and the percentage of GFP-expressing cells was
determined by ﬂow cytometry. All experiments were carried out in
triplicate.
WGA blocking assay
A total of 2×105 MDBK cells were incubated with 100 μl of WGA
lectin (Sigma-Aldrich) at concentrations of 0, 0.01, 0.05, 0.1, or 0.5 mg/
ml on ice for 1 h. WGA-treated or untreated cells were mixed with
various Ad vectors and kept on ice for 1 h. The rest of the procedure
was the same as described above for neuraminidase treatment.
M. amurensis agglutinin (MAA) and S. nigra agglutinin (SNA) treatment
A total of 2×105 MDBK cells were incubated with 100 μl of MAA
(Vector Labs, Burlingame, CA) or SNA (Sigma-Aldrich) at concentra-
tions of 0, 0.01, 0.05, 0.1, or 0.5mg/ml in BB and incubated on ice for 1 h.
MAA/SNA treated or untreated MDBK cells were mixed with BAd-GFP
or EGFPNAd5F37 and kept on ice for 1 h. The rest of the procedurewas
the same as described above for neuraminidase treatment. The
negative controls (Mock-infected) had a background level around
0.2–0.4% and the positive controls (HAd-GFP-infected) showed that
approximately 25–30% cells expressed GFP, suggesting that the cells
used in the experiments were competent for virus uptake.
Sodium periodate (NaIO4) treatment
A total of 2×105 MDBK cells were incubated with 100 μl of
periodate (Acros Organics, Morris Plains, NJ) at concentrations of 0,
0.01, or 0.1 mM in PBS at room temperature for 30 min. The unreacted
periodate was neutralized by adding two volumes of 0.22% (v/v)
glycerol in PBS (Stevenson et al., 2004). Treated or untreated cells
were washed twice with BB, kept on ice and mixed with BAd-GFP or
EGFPNAd5F37 and incubated on ice for 1 h. The rest of the procedure
was the same as described above for neuraminidase treatment. The
negative controls (Mock-infected) had a background level around 0.2–
0.4% and the positive controls (HAd-GFP-infected) showed that
approximately 25–30% cells expressed GFP, suggesting that the cells
used in the experiments were competent for virus uptake.
Protease treatment
A total of 2×105 MDBK cells were incubated with 100 μl of trypsin
(Invitrogen, Life Technologies Corp., Carlsbad, CA) at concentrations of
0, 50, or 500 μg/ml or with 100 μl of bromelain (Sigma-Aldrich) at
concentrations of 0, 200, or 2000 mU/ml in PBS at 37 °C for 30 min.
Cells were then washed twice with BB, kept on ice and mixed with
BAd-GFP or EGFPNAd5F37 and incubated for 1 h. The rest of theprocedure was the same as described above for neuraminidase
treatment.
Virus overlay protein binding assay (VOPBA)
In order to investigate whether neuraminidase treatment of MDBK
cells affects BAd3 binding to cell membrane proteins, a VOPBA assay
was carried out using cell membrane fractions from neuraminidase-
treated or untreated MDBK cells. Fourteen 150 mm plates of MDBK
cells at approximate 90% conﬂuence were treated with PBS-EDTA and
washed twice with BB. Cells from seven plates were treated with
1 mU/ml neuraminidase in BB, and cells from the remaining seven
plates were mock-treated with BB at 37 °C for 2 h and washed twice
with cold PBS. Neuraminidase-treated or untreated cells were used for
the extraction of membrane proteins as previously described (Wu et
al., 2001). Brieﬂy, cells were resuspended in the membrane solution
[250 mM sucrose, 1 mM EDTA, 20 mM HEPES, pH 7, with protease
inhibitors cocktail including Phenylmethylsulfonyl Fluoride and
Aprotinin (Sigma-Aldrich)] and incubated on ice for 10 min. This
was followed by homogenization with Dounce homogenizer and
centrifugation at 3500 rpm to remove the cellular debris. The
supernatant was centrifuged at 35,000 rpm for 1 h, and the pellet
was resuspended in 0.01 M Tris, pH 8.0 containing protease inhibitors
and used for VOPBA. Membrane proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
blotted onto a nitrocellulose membrane. Non-speciﬁc binding was
blocked by 5% skimmed milk powder solution at room temperature
for 1 h. The blots were overlaid with wild type BAd3 virus at a
concentration of 10 μg/ml or were mock-treated without virus. The
washed blots were then incubated with 1:1000 diluted rabbit anti-
BAd3 polyclonal serum (Moffatt et al., 2000) at room temperature for
1 h. The washed blots were then incubated with 1:2000 diluted horse
radish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin
IgG (H+L) (Bio-Rad, Hercules, CA) at room temperature for 1 h. The
presence of the bound virus was detected by chemiluminescence
detection system-SuperSignalR West Pico (Thermo Fisher Scientiﬁc
Inc), and digital images were captured using a Kodak Image Station
(Kodak, Rochester, NY). Efﬁciency of neuraminidase treatment of
MDBK cells that were used for VOPBA was monitored by evaluating
inhibition of BAd-GFP transduction.
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